LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,175.00
+5.00 (0.23%)
At close: Dec 5, 2025
-13.35%
Market Cap 161.47B
Revenue (ttm) 89.36B
Net Income (ttm) -35.81B
Shares Out 74.24M
EPS (ttm) -480.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 439,111
Average Volume 698,809
Open 2,180.00
Previous Close 2,170.00
Day's Range 2,140.00 - 2,185.00
52-Week Range 1,991.00 - 3,915.00
Beta -0.10
RSI 44.55
Earnings Date Nov 14, 2025

About LabGenomics

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 084650
Full Company Profile

Financial Performance

In 2024, LabGenomics's revenue was 85.90 billion, an increase of 20.85% compared to the previous year's 71.08 billion. Losses were -23.80 billion, 409.1% more than in 2023.

Financial Statements

News

There is no news available yet.